Wang Bing, Dong Jun, Niu Lijing, Chen Wenyan, Chen Dongliang, Shen Chengyi, Zhu Jiang, Zhang Xiaoming
The Chemical Biology Group, Sichuan Key Laboratory of Medical Imaging, North Sichuan Medical College, Nanchong, China.
Department of Chemistry, School of Basic Medical Science, North Sichuan Medical College Nanchong, China.
J Biomed Mater Res B Appl Biomater. 2017 Aug;105(6):1369-1378. doi: 10.1002/jbm.b.33669. Epub 2016 Apr 9.
Electrospun membranes of poly(p-dioxanone-co-l-phenylalanine) (PDPA) hold potential as an anti-adhesion material. Since adjustable degradation properties are important for anti-adhesion materials, in this study, the in vitro and in vivo degradation processes of PDPA electrospun membranes were investigated in detail. The morphological analysis of these membranes revealed the main degradation conditions of PDPA membranes. The weight remaining and molecular weight variation showed that the overall degradation rate of the membranes could be adjusted by modulating the molecular structure of the PDPAs. Especially, α-chymotrypsin could catalyze the degradation process of PDPAs. Based on these results, the in vitro degradation mechanism was demonstrated, and confirmed by H NMR of the hydrolysis products. Finally, the in vivo degradation and biocompatibility of different PDPAs were investigated. The kinetic study showed that the in vitro and in vivo molecular weight loss of PDPAs have the first-order characteristics. The in vivo degradation rate of the most Phe-containing PDPA-3 is the slowest, and this result relates to the biocompatibilities of PDPAs. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 1369-1378, 2017.
聚(对二氧六环酮 - 共 - L - 苯丙氨酸)(PDPA)电纺膜有望成为一种抗粘连材料。由于可调节的降解性能对于抗粘连材料很重要,因此在本研究中,详细研究了PDPA电纺膜的体外和体内降解过程。这些膜的形态分析揭示了PDPA膜的主要降解条件。剩余重量和分子量变化表明,膜的整体降解速率可通过调节PDPA的分子结构来调整。特别是,α - 胰凝乳蛋白酶可以催化PDPA的降解过程。基于这些结果,证明了体外降解机制,并通过水解产物的1H NMR得到证实。最后,研究了不同PDPA的体内降解和生物相容性。动力学研究表明,PDPA的体外和体内分子量损失具有一级特征。含苯丙氨酸最多的PDPA - 3的体内降解速率最慢,这一结果与PDPA的生物相容性有关。©2016威利期刊公司。《生物医学材料研究杂志》B部分:应用生物材料,105B:1369 - 1378,2017。